-
April 2010
NeuClone is among the first recipients to recieve government funding by Commercialisation Australia.
-
NeuClone is among the first recipients to receive government funding by Commercialisation Australia– the Government’s new body to help Australian inventors, entrepreneurs and researchers turn their ideas into money-making products and services. NeuClone is establishing a platform technology for the commercial production of protein therapeutics. The project will contribute to the company’s proprietary processes and technology leading to the generation of industrial organisms producing biopharmaceuticals. The company is building on its international and domestic networks with potential partnering opportunities likely to emerge with other Australian companies and academic institutions all in the support of a flourishing national biopharmaceutical industry. As a global exporter of high-tech products and services, NeuClone is contributing to the country’s trade balance in high- tech, non-resource exports.